Qube Research & Technologies LTD Gossamer Bio, Inc. Transaction History

Qube Research & Technologies LTD

$91.4 Billion
Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 208,789 shares of GOSS stock, worth $565,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares

208,789

Previous 249,784 16.41%

Holding current value

$565,818

Previous $307,000 78.83%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.21 - $3.46 $49,603 - $141,842	-40,995 Reduced 16.41%	208,789 $549,000
Q2 2025 Aug 14, 2025	SELL	$0.78 - $1.44 $503,677 - $929,865	-645,740 Reduced 72.11%	249,784 $307,000
Q1 2025 May 15, 2025	BUY	$0.85 - $1.53 $169,667 - $305,401	199,609 Added 28.68%	895,524 $985,000
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $308,523 - $500,182	467,460 Added 204.62%	695,915 $626,000
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $36,985 - $58,521	46,817 Added 25.77%	228,455 $226,000

Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $243,803 - $607,119	-478,047 Reduced 72.47%	181,638 $163,000
Q1 2024 May 14, 2024	BUY	$0.8 - $1.51 $344,874 - $650,950	431,093 Added 188.59%	659,685 $778,000
Q4 2023 Feb 13, 2024	BUY	$0.48 - $1.08 $109,724 - $246,879	228,592 New	228,592 $208,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $112,726 - $175,991	-115,027 Reduced 57.58%	84,744 $101,000
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $191,780 - $583,331	199,771 New	199,771 $251,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $827,506 - $1.71 Million	114,772 New	114,772 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $400,604 - $669,016	-67,103 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.44 - $12.49 $566,349 - $838,116	67,103 New	67,103 $582,000
Q3 2021 Nov 12, 2021	SELL	$7.25 - $13.23 $96,214 - $175,575	-13,271 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $106,168 - $129,392	13,271 New	13,271 $108,000
Q3 2020 Nov 12, 2020	SELL	$11.3 - $14.75 $302,941 - $395,432	-26,809 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $255,221 - $428,407	26,809 New	26,809 $349,000

Others Institutions Holding GOSS

# of Institutions

180

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Gossamer Bio, Inc. Transaction History